Q3 2025 iRhythm Technologies Inc Earnings Call Transcript
Key Points
- iRhythm Technologies Inc (IRTC) reported a strong revenue growth of 31% year-over-year for Q3 2025, reaching $192.9 million.
- The company achieved a record performance in both ZoMonitor and GOAT, with significant expansion in primary care and innovative health channels.
- iRhythm Technologies Inc (IRTC) is generating positive free cash flow earlier than anticipated, expecting to be free cash flow positive on an annual basis for the first time in its history.
- The company has successfully integrated 76 of its top 100 customers with EHR systems, leading to a 25% increase in monitoring volume within the first six months.
- iRhythm Technologies Inc (IRTC) is advancing its AI capabilities and expanding into adjacent markets such as sleep apnea, reinforcing its position as a comprehensive digital health platform.
- Despite strong evidence supporting its monitoring services, nearly 2 million short-duration Holter and event monitors continue to be prescribed annually in the US, representing a missed market opportunity.
- The company faces uncertainties with FDA timelines for the approval of its ZUMCT product, impacting its ability to forecast contributions from this product in 2026.
- iRhythm Technologies Inc (IRTC) is still addressing FDA remediation efforts related to a warning letter and 483 observations, with progress delayed due to the FDA shutdown.
- The innovative channel partnerships, while growing, have a variable sales cycle, making it challenging to predict their impact on future revenue.
- The company is cautious about including contributions from innovative channels and MCT in its 2026 guidance due to external dependencies and approval timelines.
Good afternoon.
Thank you for attending today's iRhythm Technologies Inc. Q3 2025 earnings conference call. My name is Jayla and I'll be a moderator for today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. At this time, I'd like to turn the conference over to our host Stephanie Beckovich, the senior director of investor relations. Please proceed.
Thank you all for participating in today's call. Earlier today, I released financial results for the 3rd quarter ended September 30th, 2025. Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1,995. Any statements contained in this call are not statements of historical fact, should be deemed to be forward-looking statements. These
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
